U.S. General Merchandise and Department Stores Stock News

IDEXX Laboratories (IDXX) moved back into focus after its Q2 2026 earnings report, as strong revenue and EPS figures, combined with higher full-year guidance, drew fresh attention from investors. Despite the upbeat Q2 2026 report, IDEXX Laboratories' short term share price momentum has been weak, with the stock down about 4% over the past month and about 19% year to date. The 3 year total shareholder return of roughly 7% contrasts with a decline over 5 years, suggesting longer term investors...

M&T Bank stock has more than doubled over the past three years, yet today some valuation checks suggest the current share price may still sit below a conservative intrinsic value estimate. At the same time, broader cross checks paint a mixed picture rather than a clear bargain, which makes the current level more interesting for investors who care about price paid. M&T Bank has returned 108.1% over the past three years, which sets a high bar for any further upside from here. The bank’s...

Zhihu stock barely flinched after earnings, slipping only 0.6% to US$3.06, yet the numbers behind that calm tape tell a more conflicted story. Revenue in Q2 landed at RMB 690.1m with a modest quarter on quarter pickup, while the company still reported a net loss and a loss per share. The emotional pull for the market sits in one place: Zhihu is squeezing its way toward leaner operations as operating expenses declined year on year, but the business remains in the red. Like the push toward...

Four Corners Property Trust (FCPT) stock recently drew fresh attention after a period in which the share price declined about 3% over the past month, while showing a gain of roughly 1% over the past 3 months. Looking beyond the recent pullback, Four Corners Property Trust has a 1-year total shareholder return of 4.82% and a 3-year total shareholder return of 18.99%, while the share price is up 8.35% year to date at about $25.18, which suggests momentum has been relatively steady rather than...

Veeva Systems just put a 15.2% one day surge in front of investors and asked a blunt question: Is the long term thesis on quality, sticky life sciences software finally lining up with the quarterly print? Coming into the release, the stock already carried a rich 45.2x trailing P/E and a reputation for premium pricing on growth. The headline this quarter is earnings power. Fiscal Q2 basic earnings per share landed at US$1.68 on revenue of US$927.96m. Net income excluding extra items reached...

CSX stock has delivered a strong 77.5% return over the past three years, yet the current valuation checks suggest the shares trade at a premium to what the intrinsic value estimate implies. Both the Discounted Cash Flow (DCF) intrinsic value and market multiple signals point to the stock being overvalued, even after this run. The 77.5% three year return indicates that CSX has already rewarded shareholders significantly, which can reduce the margin of safety for new buyers at today’s...

In recent coverage, Whirlpool has been reported as facing significant end‑market pressure, with multi-year declines in annual sales, earnings per share, and elevated net debt that raises the risk of forced asset sales or dilutive financing if performance weakens further. At the same time, Whirlpool is marking 115 years in American homes with a national appliance giveaway, underscoring how its deep brand presence contrasts with the financial strain highlighted by deteriorating profitability...

Eagle Materials (EXP) has drawn investor attention after a period of weaker share performance, with the stock down about 11% over the past month and roughly 11% over the past 3 months. Zooming out, Eagle Materials’ share price is now at $197.71, with the stock down over the past month and year to date, while the 1 year total shareholder return has also declined. Over 3 and 5 years, however, total shareholder returns remain positive, which points to longer term holders still being ahead...

Abercrombie & Fitch stock slipped 1.35% to US$145.75 by the close, which hardly matches the scale of the quarter it just put up. Q2 basic earnings per share landed at US$4.20 on net income of about US$183.7m, powered in part by a sizeable tariff refund that padded operating margins and headline profit. For short term traders, the modest red on the screen might feel underwhelming after a run that has nearly doubled the stock over three months. Longer term investors will be more focused on what...

Lantronix shareholders woke up to a very different tape today than they have seen in recent months. The stock jumped about 6% in regular trading, even though it is still down roughly 20% over the past quarter. The spark was a quarter where revenue reached about US$31.2m and the company inched close to break even on a GAAP basis while posting solid non GAAP profit. The short term move is eye catching. The real story sits in the emerging profit trend, the cash rich, debt free balance sheet and...

Saul Centers (BFS) recently drew investor attention after its latest trading session, with the stock closing at US$33.45. The move came as the real estate investment trust continued to trade below some valuation estimates. Over the past month Saul Centers’ share price return fell 5.7%. The stock remains up 6% year to date, and the 1-year total shareholder return of 6.2% suggests modest positive momentum when dividends and price changes are taken together. Compare the recent pullback in Saul...

HP stock slipped about 3% to US$29.63 today even as the company posted record Q3 revenue of US$15.7b and raised its full year earnings and free cash flow guidance. The market focused on the red on the screen. Long term investors are more likely to focus on what this quarter indicated about margins and cash. The core story this time is margin pressure meeting a valuation that already prices in slow growth. Operating margin came in at 6.5%. Management still leaned on tariff refunds and cost...

Nutanix stock closed up 6.8% at US$69.84, which indicates sentiment came in hot. The question is whether that enthusiasm lines up with what the earnings actually delivered. The headline is simple: the company reported a cloud software style quarter with US$757 million in Q4 revenue and very high non GAAP gross margin of 87.7%, while free cash flow for the year reached US$841 million. The market seems to be cheering a profitability story that has turned sharply stronger, not just a one off tax...

JinkoSolar came into this earnings print with a stock already under pressure, down sharply over the past three months and slipping a further 1.1% to US$13.51 today. The long term thesis around ultra low valuation and a potential profit recovery just met a harsher reality. Q2 2026 revenue of ¥12,356.9m barely moved quarter on quarter while the net loss widened to ¥697.3m and gross margin sat at 4.2%. For a company often framed as a high growth solar leader trading on a fraction of peer P/S...

Kohl’s stock barely flinched after earnings, up just 1.2% to about $18, even as the report put the spotlight squarely on valuation. The retailer is trading on a trailing P/E of 7.6x, while many multiline retail peers sit much higher. That leaves investors asking whether the modest price move reflects patience or hesitation. Under the surface, Kohl’s delivered quarterly earnings per share of about $1.34 on revenue of $3.5b, with same-store sales slightly negative. The key point for this...

BridgeBio Pharma (NasdaqGS:BBIO) has begun dosing patients in its ASCEND-ATTR Phase 3b/4 trial of acoramidis in transthyretin amyloid cardiomyopathy (ATTR-CM). The study is designed to assess whether acoramidis can drive disease regression and sustained cardiac improvement beyond symptom control in ATTR-CM patients. The ASCEND-ATTR trial represents a new clinical stage for acoramidis that could influence future treatment decisions for cardiologists and patients. This push by BridgeBio...

Parker-Hannifin recently filed an omnibus shelf registration covering debt, common and preferred equity, depositary shares, warrants, and stock purchase instruments, while also affirming a US$2.00 regular quarterly dividend and completing a share repurchase program totaling 31,398,426 shares for about US$6.88 billion. Taken together, the expanded financing toolkit, ongoing cash returns via dividends, and long-running buyback program highlight Parker-Hannifin’s emphasis on balance-sheet...

In recent days, Reinsurance Group of America has drawn attention as Zacks highlighted its favorable valuation metrics, strong earnings outlook, and industry-supported business momentum, including participation in the pension risk transfer market and ongoing product repricing efforts. An interesting angle is how RGA’s solid in-force book and increasing use of automation and digital underwriting are being viewed as drivers of more predictable earnings and operational efficiency within the...

In August 2026, Cushman & Wakefield expanded its capabilities by hiring loan restructuring specialist Steve Klein as Managing Director, adding veteran tenant rep broker Drew Morris in Houston, and securing the exclusive listing assignment for GO Industrial’s 1,100,500-square-foot industrial project in Phoenix. Together with Cushman & Wakefield’s report of a very large year-over-year jump in Tri-State industrial leasing and positive net absorption, these moves highlight the firm’s deeper...

SFL stock inched 2.7% higher to US$12.35 into the close, a measured move for a company that just put a much stronger earnings picture on the table. The market seemed willing to pay up a little for stability, but not yet buying into the full story. The headline is simple. SFL delivered Q2 revenue of about US$200.8m and net income of about US$33.8m, with basic earnings per share around US$0.25. For a capital intensive shipping and energy lessor, the real focus for investors was solid profit...

Phibro Animal Health has delivered very strong 3 year share price gains, yet the stock still screens as undervalued on the broader valuation checks. For investors, that raises the question of whether the recent performance has already captured most of the opportunity or if the current pricing still leaves room for upside. Phibro Animal Health is up about 160.8% over 3 years, which puts recent returns well ahead of many slower growing peers in the animal health space. The valuation outlook...

Dycom Industries stock eased about 1% today, extending a soft patch that has left the shares down over the past week, month and quarter. That cool reaction sits awkwardly against a quarter in which Dycom posted record revenue of about US$2.0b and adjusted earnings per share of US$5.29, both ahead of its own outlook. The market seems more focused on what comes next. Dycom raised full year revenue guidance into the mid US$7b range and highlighted a US$12.2b backlog. For investors, the focus now...

Mercantile Bank stock has delivered a strong 5 year return, yet current valuation checks suggest the market price may still sit below a conservative view of intrinsic value. The Excess Returns model points to a meaningful discount, while traditional earnings multiples look broadly in line with peers. Over the past 5 years, Mercantile Bank has returned 125.9%, which puts recent share price moves in the context of a stock that has already created substantial value for long term holders. The...

Constellation Brands stock has retreated sharply over the past three years, yet it still screens as undervalued on broader checks. This puts its current share price under close scrutiny for value focused investors. The share price is down about 46.1% over the past three years, which puts recent weakness at the center of any valuation discussion. Management focus on consumer insights and execution, along with a planned US$100 million commitment to its agricultural supply chain, may support...